STOCK TITAN
  1. Home
  2. News
  3. UCBJY

UCB SA - UCBJY STOCK NEWS

IMPACT
SENTIMENT
SHCR : Nasdaq UCBJY : OTC
Sharecare and UCB to present on future of decentralized clinical research at 2021 CNS Summit
conferences clinical trial
IMPACT
SENTIMENT
UCBJY : OTC
Unique Patient-led and Co-authored Analysis of the Experience of Living with Myasthenia Gravis Published in Neurology and Therapy
IMPACT
SENTIMENT
UCBJY : OTC
UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab
IMPACT
SENTIMENT
UCBJY : OTC
Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab
IMPACT
SENTIMENT
UCBJY : OTC
New Bimekizumab Two-Year Data in Moderate to Severe Plaque Psoriasis Presented at the 30th European Academy of Dermatology and Venereology Congress
IMPACT
SENTIMENT
UCBJY : OTC
"The New England Journal of Medicine" Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis
clinical trial
IMPACT
SENTIMENT
UCBJY : OTC
UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
conferences
IMPACT
SENTIMENT
UCBJY : OTC
Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs
IMPACT
SENTIMENT
UCBJY : OTC
UCB Full Year Report 2020: UCB - sustaining growth, now and into the future
IMPACT
SENTIMENT
UCBJY : OTC
UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development
Stock UCBJY logo
UCB SA
Nasdaq:UCBJY

UCBJY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link